Cargando...
Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian Cancer
Our primary objective is to review the safety and tolerability profile of olaparib, a novel anticancer therapy, and to discuss key considerations for symptom management in patients with advanced ovarian cancer. Olaparib is the first of a new class of anticancer therapies, poly (ADP-ribose) polymeras...
Guardado en:
| Publicado en: | Oncologist |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AlphaMed Press
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4978548/ https://ncbi.nlm.nih.gov/pubmed/27256873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0268 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|